RB

Ryan Bethencourt

CEO @ Wild Earth Inc | Plant-Based Protein

Raleigh-Durham-Chapel Hill Area

Invests in

Skills

Biotechnology
Clinical Development
Clinical Trials
Pharmaceutical Industry
Biopharmaceuticals
Lifesciences
Clinical Research
Start-ups
Strategy
Regulatory Affairs
Drug Development
Commercialization
Entrepreneurship
Market Research
Business Development
CRO
Sales
Neuroscience
Medical Writing
Oncology

Education

Work Experience

  • CEO

    2017

    Wild Earth is challenging the status quo with complete, sustainable, plant based protein pet food made cruelty free.

  • Managing Partner

    2020

    We back early stage founders building leading food companies that are:
 • Plant-based • Cell-based • Recombinant. SFV will not invest in any companies involved in animal agriculture.

  • Partner

    2017

    I am the lead biotech investment partner for Babel Ventures, a pre-seed/seed stage fund focused on investing in emerging biotech companies in Seed and Series A. Our current portfolio includes, Blue Land, Occamz Razor, Nebia, Vitagene, CUE, Forever labs, Zbiotics and Finless Foods.

  • Board Member

    2020

2019

  • Founding Family Member

    2019

    UMANA, Inc is a multi-family office based in San Francisco, CA, that focuses on serving HNWI (High Net Worth Individuals) with a net worth of $10M to $300M. UMANA serves some of the world's most powerful, influential, and misunderstood individuals. From Silicon Valley Tech Founders to Influencers, Conscious Athletes & Celebrities, with the mission of creating and redefining wealth. UMANA is home to a caring and pioneering team that deliver the united capabilities of wealth management, trusted advisor, house of funds, and venture studio. We are redefining the meaning of wealth, forming the most influential, caring, and awakened family in the world. A family by conscious choice.

  • Advisor

    2018

    UCSF Health Hub is a non-profit Growth Studio supported by donors. UCSF Healthhub connects ideas and companies with the people, expertise, and capital needed to grow and scale breakthrough healthcare solutions.

  • Advisor

    2017

    InterVenn Biosciences combines AI/ML, glycoproteomics & LC/MS for biomarker and target discovery in Oncology and other disease indications.

  • Board Member

    2020 - 2024

2020 - 2023

  • Board Member

    2020 - 2023

2014 - 2017

  • Co-Founder, Program Director and Venture Partner (IndieBio)

    2014 - 2017

    I co-founded IndieBio (an SOS Ventures backed accelerator and early stage seed fund) to focus on accelerating biology, through investment, mentoring and a wetlab (located in Downtown San Francisco) to assist scientists in becoming world changing entrepreneurs. I funded and built 68 biotech companies with my team running the gamut of biotechnology, food, green biomaterials, consumer goods, medicine and diagnostics. Our aim was to fund and build breakthrough companies with the aim of solving some of the world's most intractable problems, to help all of humanity's 7+ billion people. Some of our most notable alumni include, Clara Foods, Pembient, Ranomics, Zymochem, Orphidia, Ava Labs, Blue Turtle, New Wave Foods, Memphis Meats, NERD Skincare, Koniku, Girihilet, Geltor, Amino labs, SyntheX, QIDNI labs, Mycoworks, Miraculex, Ardra, Amaryllis Nucleics, Jungla, Knox, Catalog Technologies, Neuroqore, Ravata, Viaex, Bioinspira, Pure Cultures, Animal Biome, Venomyx Therapeutics, Ravata, Scaled Biolabs, The NotCo, Prellis Biologics, Bioaesthetics and many more!